Cancer incidence among HIV/AIDS population in Hubei province
10.3760/cma.j.cn114798-202003303-00225
- VernacularTitle:人类免疫缺陷病毒感染/艾滋病者恶性肿瘤的类型及其标化发生率分析
- Author:
Liping DENG
1
;
Yong XIONG
;
Zainab Isatu SESAY
;
Shicheng GAO
;
Xi′en GUI
;
Shihui SONG
;
Pingzheng MO
;
Di DENG
;
Yan XIONG
;
Yongxi ZHANG
Author Information
1. 武汉大学中南医院感染科 430071
- From:
Chinese Journal of General Practitioners
2020;19(8):737-740
- CountryChina
- Language:Chinese
-
Abstract:
The data of patients with HIV/AIDS from Hubei Province during 2004 to 2018 were obtained from the National AIDS Comprehensive Prevention and Control Information System. A total of 22 980 HIV-positive or AIDS patients were followed up for 113 164 person-years and 323 malignant tumors were diagnosed. Non-Hodgkin′s lymphoma (NHL), cervical cancer, liver cancer, lung cancer, and Kaposi sarcoma (KS) accounted for 70.0% (226/323) of all malignant tumors in this population. The average crude incidence and mortality of malignant tumors in HIV-infected patients were 285.43/100 000(269.11/100 000 in males and 325.87/100 000 in females), and 169.67/100 000(184.78/100 000 in males and 132.19/100 000 in females), respectively. The result indicates that the overall cancer incidence and mortality in HIV/AIDS population under widely implementation of combination anti-retroviral therapy (cART) are similar to those in the general population of the region. But the incidence and mortality of AIDS-related tumors such as KS, NHL, HD and cervical cancer are higher than those in general population, and attention should be given to screening of these malignancies in HIV/AIDS population.
